Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

The effect of a stability and coordination training programme on balance in older adults with cardiovascular disease: a randomised exploratory study.

Segev D, Hellerstein D, Carasso R, Dunsky A.

Eur J Cardiovasc Nurs. 2019 Jul 21:1474515119864201. doi: 10.1177/1474515119864201. [Epub ahead of print]

PMID:
31328540
2.

Effects of the antidepressant medication duloxetine on brain metabolites in persistent depressive disorder: A randomized, controlled trial.

Bansal R, Hellerstein DJ, Sawardekar S, O'Neill J, Peterson BS.

PLoS One. 2019 Jul 19;14(7):e0219679. doi: 10.1371/journal.pone.0219679. eCollection 2019.

3.

The association between antidepressant treatment and brain connectivity in two double-blind, placebo-controlled clinical trials: a treatment mechanism study.

Wang Y, Bernanke J, Peterson BS, McGrath P, Stewart J, Chen Y, Lee S, Wall M, Bastidas V, Hong S, Rutherford BR, Hellerstein DJ, Posner J.

Lancet Psychiatry. 2019 Aug;6(8):667-674. doi: 10.1016/S2215-0366(19)30179-8. Epub 2019 Jun 24.

PMID:
31248841
4.

Desvenlafaxine vs. placebo in the treatment of persistent depressive disorder.

Hellerstein DJ, Stewart JW, Chen Y, Arunagiri V, Peterson BS, McGrath PJ.

J Affect Disord. 2019 Feb 15;245:403-411. doi: 10.1016/j.jad.2018.11.065. Epub 2018 Nov 5.

PMID:
30423468
5.

A randomized trial of interpersonal psychotherapy, problem solving therapy, and supportive therapy for major depressive disorder in women with breast cancer.

Blanco C, Markowitz JC, Hellerstein DJ, Nezu AM, Wall M, Olfson M, Chen Y, Levenson J, Onishi M, Varona C, Okuda M, Hershman DL.

Breast Cancer Res Treat. 2019 Jan;173(2):353-364. doi: 10.1007/s10549-018-4994-5. Epub 2018 Oct 20.

PMID:
30343455
6.

Obstructive uropathy from complete bladder and bilateral ureteral incarceration within an inguinal hernia.

Hellerstein LH, Sacks SM, Hellerstein DK.

BMJ Case Rep. 2018 Feb 27;2018. pii: bcr-2017-222637. doi: 10.1136/bcr-2017-222637.

PMID:
29487099
7.

Pattern recognition of magnetic resonance imaging-based gray matter volume measurements classifies bipolar disorder and major depressive disorder.

Rubin-Falcone H, Zanderigo F, Thapa-Chhetry B, Lan M, Miller JM, Sublette ME, Oquendo MA, Hellerstein DJ, McGrath PJ, Stewart JW, Mann JJ.

J Affect Disord. 2018 Feb;227:498-505. doi: 10.1016/j.jad.2017.11.043. Epub 2017 Nov 13.

8.

Physical Activity-does it Really Increase Bone Density in Postmenopausal Women? A Review of Articles Published Between 2001-2016.

Segev D, Hellerstein D, Dunsky A.

Curr Aging Sci. 2018;11(1):4-9. doi: 10.2174/1874609810666170918170744. Review.

PMID:
28925889
9.

White matter tract integrity is associated with antidepressant response to lurasidone in bipolar depression.

Lan MJ, Rubin-Falcone H, Motiwala F, Chen Y, Stewart JW, Hellerstein DJ, Mann JJ, McGrath PJ.

Bipolar Disord. 2017 Sep;19(6):444-449. doi: 10.1111/bdi.12509. Epub 2017 Aug 10.

10.

Evidence for neuroplastic compensation in the cerebral cortex of persons with depressive illness.

Bansal R, Hellerstein DJ, Peterson BS.

Mol Psychiatry. 2018 Feb;23(2):375-383. doi: 10.1038/mp.2017.34. Epub 2017 Mar 7.

11.

Do social functioning and symptoms improve with continuation antidepressant treatment of persistent depressive disorder? An observational study.

Hellerstein DJ, Hunnicutt-Ferguson K, Stewart JW, McGrath PJ, Keller S, Peterson BS, Chen Y.

J Affect Disord. 2017 Mar 1;210:258-264. doi: 10.1016/j.jad.2016.12.026. Epub 2016 Dec 20.

PMID:
28064115
12.

Adapted Versus Adaptive Physical Activity.

Hutzler Y, Hellerstein D.

Adapt Phys Activ Q. 2016 Apr;33(2):109-12. doi: 10.1123/APAQ.2016-0027. No abstract available.

PMID:
27078267
13.

"The City of the Hospital": On Teaching Medical Students to Write.

Hellerstein DJ.

J Med Humanit. 2015 Dec;36(4):269-89. doi: 10.1007/s10912-015-9348-2.

14.

Vilazodone for the treatment of major depressive disorder: an evidence-based review of its place in therapy.

Hellerstein DJ, Flaxer J.

Core Evid. 2015 Apr 20;10:49-62. doi: 10.2147/CE.S54075. eCollection 2015. Review.

15.

Behavioral activation therapy for return to work in medication-responsive chronic depression with persistent psychosocial dysfunction.

Hellerstein DJ, Erickson G, Stewart JW, McGrath PJ, Hunnicutt-Ferguson K, Reynolds SK, O'Shea D, Chen Y, Withers A, Wang Y.

Compr Psychiatry. 2015 Feb;57:140-7. doi: 10.1016/j.comppsych.2014.10.015. Epub 2014 Nov 7.

PMID:
25464836
16.

Does negative affectivity predict differential response to an SSRI versus a non-SSRI antidepressant?

Gerra ML, Marchesi C, Amat JA, Blier P, Hellerstein DJ, Stewart JW.

J Clin Psychiatry. 2014 Sep;75(9):e939-44. doi: 10.4088/JCP.14m09025.

PMID:
25295437
17.

Neurocognitive predictors of antidepressant clinical response.

Bruder GE, Alvarenga JE, Alschuler D, Abraham K, Keilp JG, Hellerstein DJ, Stewart JW, McGrath PJ.

J Affect Disord. 2014 Sep;166:108-14. doi: 10.1016/j.jad.2014.04.057. Epub 2014 May 4.

18.

Combination antidepressant therapy for major depressive disorder: speed and probability of remission.

Stewart JW, McGrath PJ, Blondeau C, Deliyannides DA, Hellerstein D, Norris S, Amat J, Pilowsky DJ, Tessier P, Laberge L, O'Shea D, Chen Y, Withers A, Bergeron R, Blier P.

J Psychiatr Res. 2014 May;52:7-14. doi: 10.1016/j.jpsychires.2013.12.001. Epub 2013 Dec 17.

PMID:
24485847
19.

Mental health practitioners' use and attitudes regarding the Internet and social media.

Deen SR, Withers A, Hellerstein DJ.

J Psychiatr Pract. 2013 Nov;19(6):454-63. doi: 10.1097/01.pra.0000438184.74359.88.

PMID:
24241499
20.

Antidepressants normalize the default mode network in patients with dysthymia.

Posner J, Hellerstein DJ, Gat I, Mechling A, Klahr K, Wang Z, McGrath PJ, Stewart JW, Peterson BS.

JAMA Psychiatry. 2013 Apr;70(4):373-82. doi: 10.1001/jamapsychiatry.2013.455.

21.

A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.

Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y.

J Clin Psychiatry. 2012 Jul;73(7):984-91. doi: 10.4088/JCP.11m07230.

PMID:
22901348
22.

Abnormal functional brain asymmetry in depression: evidence of biologic commonality between major depression and dysthymia.

Bruder GE, Stewart JW, Hellerstein D, Alvarenga JE, Alschuler D, McGrath PJ.

Psychiatry Res. 2012 Apr 30;196(2-3):250-4. doi: 10.1016/j.psychres.2011.11.019. Epub 2012 Mar 6.

23.

Can people with nonsevere major depression benefit from antidepressant medication?

Stewart JA, Deliyannides DA, Hellerstein DJ, McGrath PJ, Stewart JW.

J Clin Psychiatry. 2012 Apr;73(4):518-25. doi: 10.4088/JCP.10m06760. Epub 2011 Dec 27.

PMID:
22226407
24.

Behavioral activation therapy for remediating persistent social deficits in medication-responsive chronic depression.

Erickson G, Hellerstein DJ.

J Psychiatr Pract. 2011 May;17(3):161-9. doi: 10.1097/01.pra.0000398409.21374.ab.

PMID:
21586994
25.

The impact of comorbid dysthymic disorder on outcome in personality disorders.

Hellerstein DJ, Skodol AE, Petkova E, Xie H, Markowitz JC, Yen S, Gunderson J, Grilo C, Daversa MT, McGlashan TH.

Compr Psychiatry. 2010 Sep-Oct;51(5):449-57. doi: 10.1016/j.comppsych.2009.11.002. Epub 2010 Jan 8.

26.

Impairment in psychosocial functioning associated with dysthymic disorder in the NESARC study.

Hellerstein DJ, Agosti V, Bosi M, Black SR.

J Affect Disord. 2010 Dec;127(1-3):84-8. doi: 10.1016/j.jad.2010.04.013. Epub 2010 May 14.

PMID:
20471093
27.

Escitalopram versus placebo in the treatment of dysthymic disorder.

Hellerstein DJ, Batchelder ST, Hyler S, Arnaout B, Toba C, Benga I, Gangure D.

Int Clin Psychopharmacol. 2010 May;25(3):143-8. doi: 10.1097/YIC.0b013e328333c35e.

PMID:
21811192
28.

Does personality disorder decrease the likelihood of remission in early-onset chronic depression?

Agosti V, Hellerstein DJ, Stewart JW.

Compr Psychiatry. 2009 Nov-Dec;50(6):491-5. doi: 10.1016/j.comppsych.2009.01.009. Epub 2009 Mar 10.

PMID:
19840585
29.

Predicting falls among psychiatric inpatients: a case-control study at a state psychiatric facility.

Estrin I, Goetz R, Hellerstein DJ, Bennett-Staub A, Seirmarco G.

Psychiatr Serv. 2009 Sep;60(9):1245-50. doi: 10.1176/ps.2009.60.9.1245.

PMID:
19723740
30.

Assessing behavioral coping preferences of psychiatric inpatients: a pilot study.

Hellerstein DJ, Seirmarco G, Almeida G, Batchelder S.

Medscape J Med. 2008;10(12):271. Epub 2008 Dec 2.

31.

Developing supportive psychotherapy as evidence-based treatment.

Hellerstein DJ, Markowitz JC.

Am J Psychiatry. 2008 Oct;165(10):1355-6; author reply 1356. doi: 10.1176/appi.ajp.2008.08040565. No abstract available.

PMID:
18829888
32.
33.

Practice-based evidence rather than evidence-based practice in psychiatry.

Hellerstein DJ.

Medscape J Med. 2008 Jun 16;10(6):141. No abstract available.

34.

Divergent fates of the medical humanities in psychiatry and internal medicine: should psychiatry be rehumanized?

Rutherford BR, Hellerstein DJ.

Acad Psychiatry. 2008 May-Jun;32(3):206-13. doi: 10.1176/appi.ap.32.3.206.

PMID:
18467477
35.

Aripiprazole as an adjunctive treatment for refractory unipolar depression.

Hellerstein DJ, Batchelder S, Hyler S, Arnaout B, Corpuz V, Coram L, Weiss G.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):744-50. doi: 10.1016/j.pnpbp.2007.11.024. Epub 2007 Dec 3.

PMID:
18164528
36.

Decreasing the use of restraint and seclusion among psychiatric inpatients.

Hellerstein DJ, Staub AB, Lequesne E.

J Psychiatr Pract. 2007 Sep;13(5):308-17.

PMID:
17890979
37.

Assessing obesity and other related health problems of mentally ill Hispanic patients in an urban outpatient setting.

Hellerstein DJ, Almeida G, Devlin MJ, Mendelsohn N, Helfand S, Dragatsi D, Miranda R, Kelso JR, Capitelli L.

Psychiatr Q. 2007 Sep;78(3):171-81.

PMID:
17417734
38.

Review of the american psychiatric publishing textbook of personality disorders.

Hellerstein DJ.

Psychotherapy (Chic). 2007 Mar;44(1):117-8. doi: 10.1037/0033-3204.44.1.117.

PMID:
22122175
39.

Longitudinal comparison of depressive personality disorder and dysthymic disorder.

Markowitz JC, Skodol AE, Petkova E, Xie H, Cheng J, Hellerstein DJ, Gunderson JG, Sanislow CA, Grilo CM, McGlashan TH.

Compr Psychiatry. 2005 Jul-Aug;46(4):239-45.

PMID:
16175753
40.

Dysthymic disorder: integrating research findings into clinical treatment.

Hellerstein DJ.

J Psychiatr Pract. 2001 Sep;7(5):298-309.

PMID:
15990540
41.

Aripiprazole as an adjunctive treatment for refractory major depression.

Hellerstein DJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1347-8. No abstract available.

PMID:
15588762
42.

Adapting supportive psychotherapy for individuals with Borderline personality disorder who self-injure or attempt suicide.

Aviram RB, Hellerstein DJ, Gerson J, Stanley B.

J Psychiatr Pract. 2004 May;10(3):145-55. Review.

PMID:
15330220
43.

The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.

Gelenberg AJ, Shelton RC, Crits-Christoph P, Keller MB, Dunner DL, Hirschfeld RM, Thase ME, Russell JM, Lydiard RB, Gallop RJ, Todd L, Hellerstein DJ, Goodnick PJ, Keitner GI, Stahl SM, Halbreich U, Hopkins HS.

J Clin Psychiatry. 2004 Aug;65(8):1114-9.

PMID:
15323598
44.

Citalopram in the treatment of dysthymic disorder.

Hellerstein DJ, Batchelder S, Miozzo R, Kreditor D, Hyler S, Gangure D, Clark J.

Int Clin Psychopharmacol. 2004 May;19(3):143-8.

PMID:
15107656
45.

Rating dysthymia: an assessment of the construct and content validity of the Cornell Dysthymia Rating Scale.

Hellerstein DJ, Batchelder ST, Lee A, Borisovskaya M.

J Affect Disord. 2002 Sep;71(1-3):85-96.

PMID:
12167504
46.

Vision and respect. Guidance reflects HHS' striking change in attitude toward providers and payors.

Hellerstein D.

Health Manag Technol. 2001 Sep;22(9):12-3. No abstract available.

PMID:
11552510
47.

Integrating services for schizophrenia and substance abuse.

Hellerstein DJ, Rosenthal RN, Miner CR.

Psychiatr Q. 2001 Winter;72(4):291-306.

PMID:
11525078
48.

Bupropion sustained-release for the treatment of dysthymic disorder: an open-label study.

Hellerstein DJ, Batchelder S, Kreditor D, Fedak M.

J Clin Psychopharmacol. 2001 Jun;21(3):325-9.

PMID:
11386496
49.

Effectiveness of St John's wort in major depression: a randomized controlled trial.

Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, Russell J, Lydiard RB, Crits-Cristoph P, Gallop R, Todd L, Hellerstein D, Goodnick P, Keitner G, Stahl SM, Halbreich U.

JAMA. 2001 Apr 18;285(15):1978-86.

PMID:
11308434
50.

Adding group psychotherapy to medication treatment in dysthymia: a randomized prospective pilot study.

Hellerstein DJ, Little SA, Samstag LW, Batchelder S, Muran JC, Fedak M, Kreditor D, Rosenthal RN, Winston A.

J Psychother Pract Res. 2001 Spring;10(2):93-103.

Supplemental Content

Loading ...
Support Center